MEDICAL TRANSCRIPTION BILLING, CORP. (NASDAQ:MTBCP) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

On March 7, 2018, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information furnished to Item 2.02 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such a filing.

(S)

MEDICAL TRANSCRIPTION BILLING, CORP Exhibit
EX-99.1 2 ex99-1.htm       MTBC Reports Full Year and Fourth Quarter 2017 Results   Company reports record revenue and adjusted EBITDA at top end of guidance range   Full Year 2017 Financial Results:     ● Revenue of $31.8 million for the year,…
To view the full exhibit click here